A Delayed Modified ICH Score Outperforms Baseline Scoring in Acute Intracerebral Hemorrhage.

cerebrovascular disorders clinical specialty intracranial hemorrhages neurocritical care neurohospitalist neurosurgery stroke

Journal

The Neurohospitalist
ISSN: 1941-8744
Titre abrégé: Neurohospitalist
Pays: United States
ID NLM: 101558199

Informations de publication

Date de publication:
Jul 2020
Historique:
entrez: 19 6 2020
pubmed: 19 6 2020
medline: 19 6 2020
Statut: ppublish

Résumé

The Modified Intracerebral Hemorrhage (MICH) score is a simple tool created to provide prognostication in basal ganglia hemorrhages. Current prognostic scores, including the MICH, are based on the assessment of baseline patient characteristics, failing to account for significant developments, such as intraventricular extension and clinical deterioration, which may occur over the first 72 hours. We propose to validate the MICH in all hemorrhage locations and hypothesize that its calculation at 72 hours will outperform its baseline counterpart with respect to predicting mortality and functional outcome. We performed a retrospective analysis of collated data from the Virtual International Stroke Trials Archive database. Primary outcome was 90-day mortality. Secondary outcome was poor outcome (modified Rankin Scale 4-6) at 90 days. Receiver operating characteristic curves were generated looking at the predictive ability of the MICH score for mortality and poor outcome, at baseline and at 72 hours. Competing curves were assessed with nonparametric methods. A total of 226 patients were included, with a 90-day mortality of 22.5%. The MICH scores calculated at 72 hours were more predictive of mortality than at baseline (area under the curve [AUC]: 0.89 [95% confidence interval [CI]: 0.83-0.94] vs 0.78 [95% CI: 0.70-0.85]),

Identifiants

pubmed: 32549946
doi: 10.1177/1941874419896715
pii: 10.1177_1941874419896715
pmc: PMC7271617
doi:

Types de publication

Journal Article

Langues

eng

Pagination

217-220

Informations de copyright

© The Author(s) 2019.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Neurohospitalist. 2011 Jul;1(3):148-59
pubmed: 23983850
Int J Stroke. 2012 Feb;7(2):133-8
pubmed: 22264365
Neurocrit Care. 2016 Dec;25(3):384-391
pubmed: 27160888
ISRN Stroke. 2013;2013:
pubmed: 27668123
Stroke. 2018 May;49(5):1163-1169
pubmed: 29669875
Stroke. 2008 Aug;39(8):2304-9
pubmed: 18556582
Neurology. 2011 Apr 5;76(14):1238-44
pubmed: 21346218
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Crit Care Med. 2008 Jul;36(7):2151-6
pubmed: 18552701
Stroke. 2001 Apr;32(4):891-7
pubmed: 11283388
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Neurology. 2017 Aug 1;89(5):423-431
pubmed: 28679602

Auteurs

Ronda Lun (R)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Vignan Yogendrakumar (V)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Dylan Blacquiere (D)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Michel Shamy (M)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Grant Stotts (G)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Dar Dowlatshahi (D)

Ottawa Stroke Program, Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Classifications MeSH